Clinical Trials Sponsored by MYR GmbH

Total 3777 results

Biotronik Vertriebs-GmbH

Terminated

BIOFLOW-III Romania Satellite Registry

Myocardial Ischemia | Coronary Artery Disease

Romania
Desitin Arzneimittel GmbH

Completed

Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration (LCD18K)

Fasted State

Bulgaria
Merz Pharmaceuticals GmbH

Completed

Contractubex Treatment in Scars After Abdominal Caesarean Section (ConMex)

Scars

Mexico
GWT-TUD GmbH

Terminated

Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia (August2)

Diabetic Foot | Critical Limb Ischemia

Germany
GWT-TUD GmbH

Terminated

Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia (August-1)

Diabetic Foot | Type 2 Diabetes Mellitus | Critical Limb Ischemia

Germany
Valneva Austria GmbH

Completed

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis
Valneva Austria GmbH

Completed

Virological Response Study of the HCV Vaccine IC41

Chronic Hepatitis C

Germany, Poland, Romania
Merz Pharmaceuticals GmbH

Completed

Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients

Healthy Volunteers and Glaucoma Patients

Germany
Isarna Therapeutics GmbH

Completed

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Glioblastoma | Anaplastic Astrocytoma

Germany, Austria, Georgia, India, Israel, Russian Federation
Merz Pharmaceuticals GmbH

Completed

Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems

Memory Disorder | Subjective Cognitive Impairment | Retention Disorder, Cognitive | Memory, Concentration or Attention Problems

United Kingdom, Germany
MerLion Pharmaceuticals GmbH

Completed

Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects

Healthy

United Kingdom
Merz Pharmaceuticals GmbH

Terminated

Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring

Habitual Snoring

Germany
Merz Pharmaceuticals GmbH

Completed

Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia

Cervical Dystonia

Germany
Immatics Biotechnologies GmbH

Completed

IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) (IMA910-101)

Colorectal Carcinoma

United Kingdom, Romania, Belgium, Bulgaria, Germany, Hungary, Latvia, Poland, Serbia
Merz Pharmaceuticals GmbH

Completed

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2

Moderate to Severe Glabellar Frown Lines

United States, Canada
Merz Pharmaceuticals GmbH

Terminated

Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus (OLLTT)

Subjective Tinnitus

United States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
Gebro Pharma GmbH

Completed

Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee

Osteoarthritis of the Hip or Knee

Austria
Immatics Biotechnologies GmbH

Completed

IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease (IMA901-202)

Renal Cell Carcinoma

Spain, Germany, Bulgaria, United Kingdom, Austria, Hungary, Poland, Romania, Slovakia, Switzerland
Nuvo Research GmbH

Completed

PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS

Allergic Rhinitis

Germany
Gebro Pharma GmbH

Completed

S(+)-Ibuprofen Effects on Asprin Treated Volunteers

Drug Interactions

Austria
Merz Pharmaceuticals GmbH

Completed

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines (Head2Head)

Glabellar Frown Lines

United Kingdom, Germany, Austria
APOGEPHA Arzneimittel GmbH

Completed

Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity

Urologic Diseases | Urinary Incontinence | Urinary Bladder, Neurogenic | Neurogenic Urinary Bladder Disorder | Bladder Disorder, Neurogenic | Urinary Bladder Disorder, Neurogenic | Neurogenic Bladder Disorder | Urinary Bladder Neurogenic Dysfunction | Overactive Detrusor Function

Romania, Austria, Germany
Lipid Therapeutics GmbH

Unknown

A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

Abdominal Pain | Diarrhea | Ulcerative Colitis | Large Intestine

Germany, Lithuania, Romania
Merz Pharmaceuticals GmbH

Completed

Memantine - Communication Study

Alzheimer's Disease

Germany
Merz Pharmaceuticals GmbH

Completed

Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3

Skin Diseases | Wrinkles | Physiological Stress | Nasolabial Folds | Disorder of Aging

Germany
Merz Pharmaceuticals GmbH

Completed

Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects

Healthy

Germany
Merz Pharmaceuticals GmbH

Completed

Neramexane for Tinnitus

Tinnitus

Germany, Austria
Merz Pharmaceuticals GmbH

Completed

Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen

Healthy
Orphatech Pharmaceuticals, GmbH

Withdrawn

Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A

Molybdenum Cofactor Deficiency Type A

Australia
Merz Pharmaceuticals GmbH

Completed

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb

Post-stroke Upper Limb Spasticity

Czech Republic, Hungary, Poland
Mika Pharma GmbH

Completed

Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial I

Osteoarthritis

United States
Polymun Scientific GmbH

Completed

Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous Application

Healthy
U3 Pharma GmbH

Completed

Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Merz Pharmaceuticals GmbH

Terminated

Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus

Multiple Sclerosis | Nystagmus, Congenital | Nystagmus, Acquired

United Kingdom
Merz Pharmaceuticals GmbH

Completed

Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers

Healthy

Germany
Peschke Meditrade, GmbH

Unknown

Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking for Compassionate Treatment in Pediatric Patients With Progressive Keratoconus (CXL)

Progressive Keratoconus

United States
MerLion Pharmaceuticals GmbH

Completed

Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI) (FLUT)

Urinary Tract Infections

Singapore, Germany
Merz Pharmaceuticals GmbH

Completed

Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products

Healthy

Germany
Heidelberg Metasystems GmbH

Unknown

Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients

Asthma

Germany
MerLion Pharmaceuticals GmbH

Completed

First Time in Man Study of Finafloxacin Hydrochloride

Urinary Tract Infection | Helicobacter Infections

Switzerland
PAION Deutschland GmbH

Completed

Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) (DEDAS)

Stroke
PAION Deutschland GmbH

Completed

Desmoteplase in Acute Ischemic Stroke (DIAS)

Stroke

Germany
GWT-TUD GmbH

Completed

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Metabolic Syndrome

Germany
Merz Pharmaceuticals GmbH

Completed

Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

Nasolabial Folds

Germany
Miltenyi Biomedicine GmbH

Not yet recruiting

MB-dNPM1-TCR.1 in Relapsed/Refractory AML

Leukemia, Myeloid, Acute
Translumina GmbH
EVAMED

Recruiting

Evaluation of the Vivo Isar Stent System in Routine Clinical Practice (CELEBRITY)

Artery Coronary Stenosis

France
Heidelberg Engineering GmbH

Recruiting

The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study

Eyes With Normal Anterior Segment | Eyes With Abnormal Anterior Segment

United States
BSN Medical GmbH

Not yet recruiting

RCT Exudate Management Cutimed Sorbion Product Range

Venous Leg Ulcer

Germany
Endo Health GmbH

Not yet recruiting

Pilot Study to Investigate the Effect of a Dysmenorrhoea App

Dysmenorrhea
Erbe Elektromedizin GmbH

Recruiting

Feasibility of Cryobiopsy From the Bile Duct - CRYLEO (CRYLEO)

Neoplasms, Bile Duct

Germany

3

Subscribe